Researchers to pull duplicate submission after reviewer concerns and Retraction Watch inquiry 

While doing a literature review earlier this spring, a human factors researcher came across a paper he had peer-reviewed. One problem: He had reviewed it – and recommended against publishing – for a different journal not long before the publication date of the paper he was now looking at. 

Based on the published paper and documents shared with us, it appears the authors submitted the same manuscript to the journals Applied Sciences and Virtual Reality within 11 days of each other, and withdrew one version when the other was published. 

And after we reached out to the authors, the lead author told us they plan to withdraw the published version next week – which the editor of the journal had called for in April but its publisher, MDPI, had not yet decided to do. 

Continue reading Researchers to pull duplicate submission after reviewer concerns and Retraction Watch inquiry 

Correction finally issued seven years after authors promise fix ‘as soon as possible’

A journal has finally issued a correction following a seven-year-old exchange on PubPeer in which the authors promised to fix issues “as soon as possible.” But after following up with the authors and the journal, it’s still not clear where the delay occurred.

Neuron published the paper, “Common DISC1 Polymorphisms Disrupt Wnt/GSK3β Signaling and Brain Development,” in 2011. It has been cited 101 times, 28 of which came after concerns were first raised, according to Clarivate’s Web of Science. 

It first appeared on PubPeer in April 2018, when commenter Epipactis voethii first pointed out figures 2 and 3 of the paper had potential image duplication. 

Continue reading Correction finally issued seven years after authors promise fix ‘as soon as possible’

Can a better ID system for authors, reviewers and editors reduce fraud? STM thinks so

Unverifiable researchers are a harbinger of paper mill activity. While journals have clues to identifying fake personas — lack of professional affiliation, no profile on ORCID or strings of random numbers in email addresses, to name a few — there isn’t a standard template for doing so. 

The International Association of Scientific, Technical, & Medical Publishers (STM) has taken a stab at developing a framework for journals and institutions to validate researcher identity, with its Research Identity Verification Framework, released in March. The proposal suggests identifying “good” and “bad” actors based on what validated information they can provide, using passport validation when all else fails, and creating a common language in publishing circles to address authorship. 

But how this will be implemented and standardized remains to be seen. We spoke with Hylke Koers, the chief information officer for STM and one of the architects of the proposal. The questions and answers have been edited for brevity and clarity.

Continue reading Can a better ID system for authors, reviewers and editors reduce fraud? STM thinks so

Paper with duplicated images retracted four months after concerns were raised

We write plenty of stories about lengthy investigations and long wait times for retractions. So we are always glad when we can highlight when journals act in a relatively timely fashion.

The Kaohsiung Journal of Medical Sciences, published by Wiley on behalf of Kaohsiung Hospital in Taiwan, seemed to exhibit some urgency after a sleuth raised concerns in December 2024 about a 2019 paper with problematic figures. 

The sleuth, who has asked us to remain anonymous but goes by “Mitthyridium jungquilianum” on PubPeer, had pointed out similarities between the 2019 paper and another article by different authors, published in Oncotarget in 2014. One figure from each work was “more similar than expected” to each other, Mitthyridium wrote, citing ImageTwin. 

Continue reading Paper with duplicated images retracted four months after concerns were raised

Clarivate to stop counting citations to retracted articles in journals’ impact factors

Clarivate will no longer include citations to and from retracted papers when calculating journal impact factors, the company announced today

The change comes after some have wondered over the years whether citations to retracted papers should count toward a journal’s impact factor, a controversial yet closely watched metric that measures how often others cite papers from that journal. For many institutions, impact factors have become a proxy for the importance of their faculty’s research.

Retractions are relatively rare and represent only 0.04% of papers indexed in Clarivate’s Web of Science, according to the announcement. But the overall retraction rate has risen recently, to about 0.2%, which, along with a decrease in the time it takes to retract papers, motivated the policy change. Nandita Quaderi, the editor-in-chief of Web of Science, said in the announcement the policy would “pre-emptively guard against any such time that citations to and from retracted content could contribute to widespread distortions in the [journal impact factor].”

Continue reading Clarivate to stop counting citations to retracted articles in journals’ impact factors

Journal investigating placebo effect study following Retraction Watch inquiry

An Elsevier journal is investigating a paper by a controversial author after a Retraction Watch inquiry about the article. The article concluded that “placebo effects have a significant impact on observed outcomes” in both placebo and treatment groups in clinical trials. 

The senior author of the paper is Harald Walach, whose name may be familiar. In one paper, now retracted, Walach and his coauthors claimed COVID-19 vaccines killed two people for every three deaths they prevented. In a different paper, also retracted, Walach and his colleagues claimed children’s masks trap carbon dioxide; they later republished the article in a different journal. He lost two papers and a university affiliation in 2021. 

One of his latest papers, “Treatment effects in pharmacological clinical randomized controlled trials are mainly due to placebo,” appeared online December 27 in the Journal of Clinical Epidemiology

Continue reading Journal investigating placebo effect study following Retraction Watch inquiry

A ‘stupid mistake’: EPA researcher added their underage child as an author on manuscript 

A researcher at the Environmental Protection Agency added their underage child as a coauthor on a paper after the manuscript cleared the agency’s internal review, an investigation found. 

The revelation, which calls into question the EPA’s process for reviewing papers, was among several highlighted by the agency’s Office of Inspector General in an April 8 report, which is redacted for names and identifying details. 

The report cites specific concerns regarding the researcher, including that their child listed the paper among their accomplishments on college applications. These and other authorship practices revealed deeper issues with the review system at the EPA’s Office of Research and Development (ORD), which the report found “lacks oversight.” The OIG recommended the office take steps to address shortcomings, as the collaborations “remained unchecked” for “several years.” 

Continue reading A ‘stupid mistake’: EPA researcher added their underage child as an author on manuscript 

A Ph.D. in paper mills? 

Bank Phrom/Unsplash

A university and a publisher are teaming up to combat paper mills in a unique way: By enlisting a Ph.D. candidate.

In April, the Centre for Science and Technology Studies (CWTS) at Leiden University in the Netherlands announced it would be collaborating with Wiley to establish a four-year research position focused on paper mills.

“Of course one Ph.D. will not fix the problem,” said Cyril Labbé of Grenoble Alpes University in France, whose lab hosted a Ph.D. student in 2014 to detect computer-generated manuscripts. “But going this way is far more constructive than resorting to empty rhetoric and wooden language, as some publishers tend to do.”

Continue reading A Ph.D. in paper mills? 

‘Squared blunder’: Google engineer withdraws preprint after getting called out for using AI

Two of the phrases in the paper identified as AI-generated

An expert in AI at Google has admitted he used the technology to help write a preprint manuscript that commenters on PubPeer found to contain a slew of AI-generated phrases like “squared blunder” and “info picture.” 

The paper, “Leveraging GANs For Active Appearance Models Optimized Model Fitting,” appeared on arXiv.org in January but was withdrawn April 7. The author, Anurag Awasthi, is an engineering lead in AI infrastructure at Google. In a PubPeer comment, he described the paper as a “personal learning exercise.” 

In March 2025, sleuth Guillaume Cabanac, creator of the Problematic Paper Screener, pointed out in a PubPeer comment the paper included several tortured phrases. These phrases indicate AI use and occur when large language models try to find synonyms for common phrases. In Awasthi’s paper, “linear regression” became “straight relapse,” and “error rate” became “blunder rate,” among others. 

Continue reading ‘Squared blunder’: Google engineer withdraws preprint after getting called out for using AI

UC Davis research director loses three papers for image manipulation

Allen Gao

A lead researcher at UC Davis has lost three decades-old papers from the same journal for image duplication, and the journal says it is investigating more. 

Allen Gao, director of research for the Department of Urologic Surgery at the institution is first last and corresponding author on the papers, published in The Prostate

The journal retracted the articles – published in 2002, 2004 and 2009 – in  February. The papers have been cited 42, 71, and 27 times respectively, according to Clarivate’s Web of Science.

Continue reading UC Davis research director loses three papers for image manipulation